The WNT Pathway Is Relevant for the BCR-ABL1-Independent Resistance in Chronic Myeloid Leukemia

Notwithstanding the introduction of Tyrosine Kinase Inhibitors (TKIs) revolutionized the outcome of Chronic Myeloid Leukemia (CML), one third of patients still suspends treatment for failure response. Recent research demonstrated that several BCR/ABL1-independent mechanisms can sustain resistance, b...

Descrición completa

Detalles Bibliográficos

Principais autores:	Susanna Grassi, Sara Palumbo, Veronica Mariotti, Diego Liberati, Francesca Guerrini, Elena Ciabatti, Serena Salehzadeh, Claudia Baratè, Serena Balducci, Federica Ricci, Gabriele Buda, Lorenzo Iovino, Francesco Mazziotta, Francesco Ghio, Giacomo Ercolano, Antonello Di Paolo, Antonella Cecchettini, Chiara Baldini, Letizia Mattii, Silvia Pellegrini, Mario Petrini, Sara Galimberti
Formato:	Artigo
Idioma:	Inglês
Publicado:	Frontiers Media S.A. 2019-06-01
Series:	Frontiers in Oncology
Assuntos:	WNT/β-catenin PcGs JAK/STAT CML BCR/ABL1-independent resistance PCA
Acceso en liña:	https://www.frontiersin.org/article/10.3389/fonc.2019.00532/full
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!